METTL3 is associated with the occurrence and maintenance of acute myeloid leukemia (AML), so one study has explored whether STM2457, as a small molecule specific inhibitor of METTL3 enzyme, targeting METTL3 enzyme activity has anti-leukemia therapeutic potential. This evidence concerns the gene METTL3 and leukemia.